# Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Study · id `cardio:ct-nct01658410` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01658410](<https://clinicaltrials.gov/study/NCT01658410>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01658410

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01658410. Randomized; triple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01658410, source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01658410, source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01658410, source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)
- Completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT01658410, source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)
- Countries: Austria (ClinicalTrials.gov record NCT01658410, source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01658410-2012-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
- Condition: Coronary Artery Disease
- Condition: Aorto-coronary Bypass Grafting
- Intervention (Drug): BQ-123
- Intervention (Drug): NaCl
- Lead sponsor: Medical University of Vienna
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Medical University of Vienna (`cardio:org-medical-university-of-vienna`)

## Provenance

Content hash: cf77dddc61272a4fa19d2de5758e5ee834762e4f474bde509389964968b042b2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
